5020 ENEOS HD

時価

2兆4566億円

PER 予

10.36倍

2011年以降

赤字-14.68倍
（2011-2024年）

0.73倍

2011年以降

0.43-1.1倍
（2011-2024年）

3.21%

ROE 予

7.08%

ROA 予

2.32%

Increase By Corporate DivisionNA、Research And Development Expenses Research And Development Activities - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member、Other Financial AssetsCAIFRS他2件

【期間】

年度	Increase By Corporate DivisionNA		Research And Development Expenses Research And Development Activities - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member		Other Financial AssetsCAIFRS		売上高（IFRS）		投資有価証券の売却による収入
2010/12	-		-		-		-		11億
2011/12	-		-		-		-		15.8億	+44.4%
2012/12	-		-		-		-		18.6億	+17.3%
2013/12	-		-		-		-		73.2億	+293.8%
2014/12	-		-		-		-		1.1億	-98.5%
2015/12	-		-		-		-		291億	大幅増
2016/12	-		-		-		4.94兆		206億	-29.4%
2017/12	-		-		-		7.39兆	+49.6%	-
2018/12	-		-		-		8.33兆	+12.7%	-
2019/12	-		-		-		7.61兆	-8.7%	-
2020/12	-		-		-		5.37兆	-29.4%	-
2021/12	-		-		-		7.63兆	+42.2%	-
2022/12	-		-		-		11.3兆	+48.5%	-
2023/12	-		-		-		10.2兆	-9.6%	-

2010年12月

Increase By Corporate DivisionNA: -
Research And Development Expenses Research And Development Activities - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
Other Financial AssetsCAIFRS: -
売上高（IFRS）: -
投資有価証券の売却による収入: 10億9700万

2011年12月

Increase By Corporate DivisionNA: -
Research And Development Expenses Research And Development Activities - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
Other Financial AssetsCAIFRS: -
売上高（IFRS）: -
投資有価証券の売却による収入: 15億8400万

2012年12月

Increase By Corporate DivisionNA: -
Research And Development Expenses Research And Development Activities - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
Other Financial AssetsCAIFRS: -
売上高（IFRS）: -
投資有価証券の売却による収入: 18億5800万

2013年12月

Increase By Corporate DivisionNA: -
Research And Development Expenses Research And Development Activities - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
Other Financial AssetsCAIFRS: -
売上高（IFRS）: -
投資有価証券の売却による収入: 73億1700万

2014年12月

Increase By Corporate DivisionNA: -
Research And Development Expenses Research And Development Activities - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
Other Financial AssetsCAIFRS: -
売上高（IFRS）: -
投資有価証券の売却による収入: 1億1000万

2015年12月

Increase By Corporate DivisionNA: -
Research And Development Expenses Research And Development Activities - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
Other Financial AssetsCAIFRS: -
売上高（IFRS）: -
投資有価証券の売却による収入: 291億1200万

2016年12月

Increase By Corporate DivisionNA: -
Research And Development Expenses Research And Development Activities - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
Other Financial AssetsCAIFRS: -
売上高（IFRS）: 4兆9415億
投資有価証券の売却による収入: 205億6000万

2017年12月

Increase By Corporate DivisionNA: -
Research And Development Expenses Research And Development Activities - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
Other Financial AssetsCAIFRS: -
売上高（IFRS）: 7兆3944億
投資有価証券の売却による収入: -

2018年12月

Increase By Corporate DivisionNA: -
Research And Development Expenses Research And Development Activities - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
Other Financial AssetsCAIFRS: -
売上高（IFRS）: 8兆3313億
投資有価証券の売却による収入: -

2019年12月

Increase By Corporate DivisionNA: -
Research And Development Expenses Research And Development Activities - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
Other Financial AssetsCAIFRS: -
売上高（IFRS）: 7兆6071億
投資有価証券の売却による収入: -

2020年12月

Increase By Corporate DivisionNA: -
Research And Development Expenses Research And Development Activities - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
Other Financial AssetsCAIFRS: -
売上高（IFRS）: 5兆3671億
投資有価証券の売却による収入: -

2021年12月

Increase By Corporate DivisionNA: -
Research And Development Expenses Research And Development Activities - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
Other Financial AssetsCAIFRS: -
売上高（IFRS）: 7兆6313億
投資有価証券の売却による収入: -

2022年12月

Increase By Corporate DivisionNA: -
Research And Development Expenses Research And Development Activities - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
Other Financial AssetsCAIFRS: -
売上高（IFRS）: 11兆3351億
投資有価証券の売却による収入: -

2023年12月

Increase By Corporate DivisionNA: -
Research And Development Expenses Research And Development Activities - Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activities Member: -
Other Financial AssetsCAIFRS: -
売上高（IFRS）: 10兆2453億
投資有価証券の売却による収入: -